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Abstract
The Li cell adhesion molecule (LICAM) is
a neuronal gene involved in the develop-
ment of the nervous system. Mutations in
LICAM are known to cause several clini-
cally overlapping X linked mental retarda-
tion conditions: X linked hydrocephalus
(HSAS), MASA syndrome (mental retar-
dation, aphasia, shuffling gait, adducted
thumbs), spastic paraplegia type I
(SPGl), and X linked agenesis of the
corpus callosum (ACC). In an analysis of
a family with HSAS, we identified a C-T
transition (C924T) in exon 8 that was
initially thought to have no effect on the
protein sequence as the alteration affected
the third base of a codon (G308G). Exten-
sive analysis of the other 27 exons showed
no other alteration. A review of the
sequence surrounding position 924 indi-
cated that the C-*T transition created a
potential 5' splice site consensus se-
quence, which would result in an in frame
deletion of 69 bp from exon 8 and 23 amino
acids of the LICAM protein. RT-PCR of
the RNA from an affected male fetus and
subsequent sequence analysis confirmed
the use of the new splice site. This is the
first report of a silent nucleotide substitu-
tion in LICAM giving rise to an alteration
at the protein level. Furthermore, it shows
that as mutation analysis plays an ever
more important role in human genetics,
the identification of a synonymous base
change should not be routinely discounted
as a neutral polymorphism.
(7Med Genet 1998;35:456-462)
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Rosenthal et al' were the first to present
evidence for the involvement of a mutation of
the Li cell adhesion molecule (LlCAM) in X
linked hydrocephalus. The finding was consist-
ent with linkage analyses which placed both
LiCAM and X linked hydrocephalus resulting
from stenosis of the aqueduct of Sylvius
(HSAS) in Xq28,2 and studies that had impli-
cated LiCAM in neurite outgrowth.4 Subse-
quently, mutations in this neuronal glycopro-
tein were found to cause other disorders
clinically related to X linked hydrocephalus,
such as MASA syndrome (mental retardation,
aphasia, shuffling gait, adducted thumbs), X
linked spastic paraplegia type I (SPG1), and X
linked agenesis of the corpus callosum
(ACC).5 6 At present, there are over 50
LiCAM mutations listed on the LI Mutation
Web Page.7 Approximately 75% of the muta-
tions are contained within 19 exons that repre-
sent 65% of the coding sequence! These
mutations include frameshifts, missense muta-
tions, stop codons, and alterations in splice site
junctions. In almost every case, a mutation
appears limited to a single family. In a few
instances, the same mutation will give rise to
more than one of the above clinically related
genetic disorders, so that one can observe both
inter- and intrafamilial variability in families
with L1CAM mutations.616
As part of our interest in X linked mental
retardation, we have been investigating families
with HSAS and MASA. As expected, we have
observed the range of mutations in Li CAM
mentioned above.' However, in one family with
a history of HSAS over four generations, we
were unable to detect any mutation other than
a presumed silent alteration at position 924 in
which a C-iT transition affected the third
position in a glycine codon (G308G). We
present evidence that this neutral mutational
event is, in fact, the cause of HSAS as a result




The proband (IV. 1) had severe congenital
hydrocephalus associated with apparent aque-
ductal stenosis; he received a shunt at 4 days of
age. The remaining cortex was very thin. His
head circumference was within the normal
range at 3 months and was almost 1 SD below
the mean at 4 years 8 months. At the age of 7
years, a head MRI showed agenesis of the cor-
pus callosum and hydrocephalus. His hands
were held tightly clenched with the thumbs and
the third finger overlapping the second finger.
All fingers could be straightened passively
except the index fingers which were held tightly
contracted in the palms. The thumbs could be
extended more easily than the index fingers.
Therefore, he appeared to have adducted/
contracted index fingers rather than the
adducted thumb position that is sometimes
associated with HSAS.
FAMILY HISTORY
Four maternal great uncles died at birth or in
early infancy with congenital hydrocephalus;
they were brothers of the maternal grand-
mother (fig 1A). Clinical information is not
available, but they were described by the family
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Figure 1 (A) Pedigree of kindred K8715 with HSAS. (B) HphI analysis of the C924T alternation in kindred K8715.
The unaffected chromosome contains a 117 bpfragment. A chromosome with the C924T alteration contains an HphI site
in the 117 bp fragment which upon digestion gives rise to two fragments of 79 bp and 38 bp, respectively. Notation above
the lane gives the location in the pedigree in (A).
as looking like the proband. This family is fam-
ily 7 in the report by Willems et al.2
GENOMIC DNA
Blood or amniocytes were obtained with
informed consent. Genomic DNA was isolated
from peripheral blood using a high salt
method." DNA from amniocytes was prepared
using routine procedures. '2
RESTRICTION ENDONUCLEASE FINGERPRINTING
(REF)
Exons 7-10 were amplified as a 1088 bp
fragment using the following primers: ex7-1 Of:
5'CTGGGGTGGAGGGAAGAGTG3', ex7-
1 Or: 5'CCAGTGGGTGCAGGGACAGA3'.
The PCR reaction mixture contained 10
mmol/l Tris-HCl, pH 8.3, 50 mmol/l KC1, 1.5
mmol/l MgCl2, 50 [tmol/l of each dATP, dCTP,
dGTP, dTTP, 1 ,umol/l of each primer, 2.5 U of
Taq DNA polymerase (Boehringer-
Mannheim), 0.55 ptg TaqI polymerase start
antibody (Clontech), and 125 ng genomic
DNA in a 50 jtl total volume. The initial dena-
turing temperature was 94°C for five minutes.
This was followed by 35 cycles of denaturation
at 94°C for 30 seconds, annealing at 70°C for
one minute, and extension at 72°C for 1.5
minutes, followed by a final extension at 72°C
for 10 minutes. The PCR products were
checked by 1.5% agarose gel electrophoresis
before doing REF.
A total of 100 ng of the exons 7-10 PCR
product were digested separately by four
different restriction endonucleases in a total
volume of 10 [tl. The four digestion reactions
contained 4 U HhaI in NEB buffer 4, or 4 U
DdeI in NEB buffer 3, or 4 U Hinfl, or 4 U
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After digestion, all the endonucleases were
inactivated at 96°C for 10 minutes. The several
reactions were mixed together and reheated at
96°C for five minutes. Digested fragments (10
ng) were incubated with 6 ptCi y-32P ATP and 1
U T4 kinase in a buffer of 70 mmol/l Tris-HCl,
pH 7.6, 10 mmol/l MgC12, 5 mmol/l DTT at
37°C for three hours. After the labelling
reaction, 10 gl stop buffer (95% formamide, 10
mmol/l NaOH, 0.25% bromophenol blue,
0.25% xylene cyanol) were added to each tube
and 4 pl were loaded onto either a 6%
acrylamide gel or a MDE (FMC) gel sepa-
rately. The 6% acrylamide gel contained 10%
glycerol and 0.6 x TBE and was run at 8 W,
4°C for 24 hours. The MDE gel was prepared
according to the FMC instruction manual and
run at 8 W at room temperature for 12 hours.
The gels were dried and exposed to Biomax
film (Kodak, Rochester, NY, USA) at -80°C
for 1.5 hours.
SEQUENCING OF PCR PRODUCTS
PCR products (50 !tl) were run on 1% agarose
gels containing 1 x TBE. The DNA bands were
cut out and DNA was purified using QIAquick
gel extraction kit (Qiagen). DNA sequencing
was performed using thefmolDNA sequencing
system (Promega). a-33P dATP or a-35S dATP
were used in sequencing reactions and 3 ptl of
sequencing reaction was run on 6% polyacryl-
amide gel containing 7 mol/l urea at 85 W for
three to six hours.
DETECTION OF HphI POLYMORPHISM
Template DNA (100 ng) from peripheral
blood was PCR amplified in a 40 pl volume
using primers G10 and GI1 (23), which flank
458
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Figure 3 Schematic representation ofexon 8, intron 8, exon 9 organisation in LlCAM. (A) Normal genomic sequence
near the exon 8/intron 8 and intron 81exon 9 boundaries. Protein sequence of the LlCAM gene corresponding to this coding
region is given below the genomic sequence. (B) Genomic sequencefor same region in the X chromosome in K8715 which
carries the C924T alteration. The predicted amino acid sequence for the altered LlCAM protein is given below the genomic
sequence. The new 5' splice site is indicated by an arrow. In both (A) and (B), position 924 is indicated by *.
exon 8 of the L1CAM gene. The reaction con-
tained 10 mmol/l Tris-HCl, pH 8.3, 50 mmol/l
KCl, 1.5 mmolIl MgCl2, 50 gmol/l of each
dATP, dCTP, dGTP, dTTP, 1 gmol/l of each
primer, 2 U Taq DNA polymerase, and 0.44 jg
TaqI Polymerase Start antibody. The initial
denaturing was performed at 94°C for five
minutes and then followed by 35 cycles of
94°C for 30 seconds, 68°C for 30 seconds, and
72°C for one minute; the final extension was at
72°C for seven minutes. PCR product (16 il)
was digested using 8 U HphI in a 24 gl total
volume containing 50 mmol/l potassium ac-
etate, 20 mmol/l Tris-acetate, 10 mmol/l mag-
nesium acetate, 1 mmol/l dithiothteitol (pH
7.9) at 37°C for 12 hours. The digested
samples were run on a mini non-denaturing gel
containing 8% acrylamide and 15% glycerol at
170 volts and room temperature for one hour.
The gel was stained in a 0.5 ,ug/ml ethidium
bromide solution for five minutes and a gel
picture was taken using an AlphaImager 2000
(Alpha Innotech Corporation, California).
CELL CULTURE AND RNA ISOLATION
Amniocytes were maintained inMEM (Sigma)
supplemented with 20% fetal bovine serum
and 1% penicillin/streptomycin (Gibco). When
the number of the cultured cells reached 5 mil-
lion, isolation of the total RNA was accom-
plished using Rneasy mini kit (Qiagen).
CDNA PREPARATION AND RT-PCR
The total RNA was treated with DNase I
before the reverse transcription (RT) reaction.
The RT reaction was performed using 5 jg
DNase I treated total RNA containing 20
mmol/l Tris-HCl (pH 8.4), 50 mmol/l KCI, 2.5
mmol/l MgCl2, 0.5 mmol/l of each dNTP, 0.01
mol/l DDT, 250 ng random hexamer primers,
and 200 units of SuperScript II reverse
transcriptase (Gibco BRL). The reaction
conditions were according to the manufactur-
er's instructions.
cDNA mix (2 gl) from the RT reaction was
used for RT-PCR in a 50 gl volume. The PCR
reaction contained 10 mmol/l Tris-HCl (pH
8.3), 1.5 mmol/l MgCl2, 50 mmol/l KCI, 0.2
mmol/l each dATP, dCTP, dGTP, dTTP, 1
jmol/l primers of L5-lOf (5'CCTC-
CGACAACCACTCAGACTACA3') and L5-
lOr (5'CGGTTGCGGGCCTCACATT3'),
0.66 gg Taq polymerase start antibody, and 3 U
Taq polymerase (Boehringer Mannheim). The
PCR conditions were as follows: denature at
90°C for five minutes followed by 35 cycles of
denature at 94°C for 30 seconds, annealing at
62°C for one minute and extension at 72°C for
two minutes; the final extension was at 72°C
for 10 minutes. The PCR products were run on
1.2% agarose gel containing 0.5 x TBE buffer
and 0.5 ,ug/ml ethidium bromide.
Results
MUTATION ANALYSIS
The Li CAM gene was screened for mutations
using DNA from the proband in family K87 15
(IV. 1, fig 1A). Restriction endonuclease finger-
print (REF) analysis was used for 19 of the 28
exons.8 13 This method involved amplifying the
19 exons in five clustered groups: 5-6, 7-10,
11-14, 16-18, 20-24.8 REF analysis showed a
fingerprint pattern consistent with an altera-
tion in exon 8 (fig 2A). Sequence analysis of
exon 8 detected a C-*T transition at position
924 (fig 2B). This base substitution occurred in
the third base in codon 308 which encodes a
glycine, thereby creating a neutral mutation
/
459
460 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Du,Dickerson, Aylsworth, et al
~~
Figure 4 RT-PGR analysis of exons 6-10 of the LlCAM cDNA from amniocytes from the affected fetus (IV3,figlJA).
(A) Agarose gel electrophoresis of RT-PCR products generatedfrom a control (lane 1), the fetus (lane 3), and a cDNA
library (lane 5), using pri.mers gi.ven i.n Materials and methods. Lane 7 is the PCR product generated using genomic DNA
as a template. Lane 8 is a product generated using primers and RNA supplied with the SuperScript II reverse transcriptase
kit (Gibco BRL) which was used as a positive control for the RT-PCR reactions. (B) Sequence analysis of the RT§PCR
product from a control sample (left panel) and the affected fetus (right panel). The arrow in the right panel indicates the
locati'on of the 69 bp deletion in the mRNA from the affected fetus.
(G308G). The base substitution, however, did
create a new Hphl site. Analysis of the family
showed that the presence of the site segregated
with the HSAS (fig 1 B). This was consistent
with the previous haplotype analysis (data not
shown).
The remaining nine exons (1-4, 19, 25-28)
with their flanking intronic sequences were
examined using SSCP. No sequence alterations
were detected after duplicate analyses (data not
shown).
THE C924T (G308G) ALTERATION AS A MUTATION
WVhile the. family was still being investigated,
111.2 became pregnant. Amniocentesis showed
the fetus to be a male (IV.3, fig IA). Analysis of
DNA isolated from the amniocytes indicated
the X chromosome of the fetus carried the at
risk haplotype (data not shown) and the HphI
restriction site (fig 1 B). Ultrasound at 23
weeks' gestation indicated borderline to mild
ventriculomegaly. Physical examination of the
fetus after delivery at 24 weeks showed relative
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macrocephaly and clasped thumbs. Necropsy
was refused. Based on these clinical features
and the absence of any other identified
sequence alteration in the LiCAM gene, the
DNA sequence encompassing the C924T
alteration was re-examined. Re-examination of
the sequence showed that the C-*T transition
appeared to create a potential 5' splice site 69
bp upstream from the normal exon 8/intron 8
splice site (fig 3). The new consensus sequence
(TGgtgagt) had a consensus value of 0.88
while the normal splice site (GGgtatgg) had a
value of 0.76.14 In theory, the new 5' splice site
would possibly result in 69 bp being eliminated
from the mRNA (fig 3B). Furthermore, the
absence of the HphI polymorphism in 200 X
chromosomes indicated that this alteration was
not a common polymorphism in the normal
population.
Based on these findings and assumptions,
RT-PCR was performed on total RNA isolated
from amniocytes of IV3 using primers de-
signed to amplify exons 6-10 in LiCAM
mRNA. The results, presented in fig 4A,
showed a band estimated to be about 559 bp
while the band amplified from control Li CAM
mRNA contained the expected band of 628 bp.
Thus, 69 bp were apparently missing from the
Li CAM transcript of IV.3 as predicted. Direct
sequencing of the amplified fragment from IV.3
showed that the deletion involved the last 69 bp
of exon 8 (fig 4B).
Discussion
Sequence analysis of exon 8 of LI CAM in a
family with HSAS indicated a single difference
between the proband's exon and the normal
LiCAM exon 8, a thymine substituted for a
cytidine (C924T). Both the normal codon 308
(GGC) and the proband's codon 308 (GGT)
encode for glycine. This silent nucleotide sub-
stitution was not found to be a common variant
in the normal population. In fact, this neutral
mutation resulted in the activation of a new
splice site 69 bp 5' to the normal exon 8/intron
8 donor splice site (fig 3B), and segregated
exclusively with HSAS in affected subjects and
carriers in the family. The alternatively spliced
mRNA codes for a LICAM protein in which
23 amino acids (residues 308-330) are missing
from the third Ig domain. 15 This effectively
eliminates the third near 3 sheet of the domain,
undoubtedly severely affecting the activity of
the LICAM protein and its ability to induce
neurone-neurone adhesion.6 17
This mutation is notable for two reasons.
First, the mutation differs from other splice site
mutations in LI CAM and other genes that give
rise to a pathogenic phenotype as it neither
destroys the function of a normal splice site nor
creates a new splice site within an intron.6 18 A
review of published reports found that mRNA
splicing mutations account for 15% of all point
mutations causing human genetic disease.'8 Of
these, 87% (88/101) are point mutations
within either the 5' or 3' splice site consensus
sequence. The remaining point mutations
(13%) lead to creation of novel splice sites.18
Thus, the creation of a novel splice site result-
ing from the C924T transition in exon 8 in our
family is representative of a very rare muta-
tional event that accounts for about 2% of all
point mutations.
The second feature of the C924T mutation
in LICAM is perhaps more important. The
point mutation in codon 308 in our family is a
classic case of a neutral or silent mutation since
the normal codon (GGC) and the variant
codon (GGT) both encode for glycine. To our
knowledge, there have been at least six other
reports of silent mutations giving rise to a
pathogenic phenotype. Goldsmith et al'8 re-
ported a T-*A substitution in codon 24 of the
f globin gene that did not alter the amino acid
as both normal and variant codon encoded for
glycine. Using a gene expression system, the
authors proved that the substitution caused
abnormal mRNA splicing in a patient with P
thalassaemia."9 The second report was of an
A-*G substitution in the third position of a
lysine codon of the factor IX gene in a patient
with haemophilia B.20 Although the altered
sequence had a splice donor consensus value of
1.00, the authors did not prove that alternate
mRNA splicing occurred in their patient. As no
other mutation was found, the authors pre-
sumed the silent A-*G substitution to be
pathogenic.20 Baumbach et a12' reported a neu-
tral mutation (C766T) in the third position of
codon 236 of the growth hormone receptor
(GH-R) gene. The mutation was shown to cre-
ate a cryptic splice site 63 bp 5' to the normal
exon 7 splice site, thereby eliminating 21 amino
acids from the GH-R. Homozygosity for this
mutation results in Laron's syndrome in a
genetic isolate in the Bahamas.2' A neutral G to
A transition in the third position of the alanine
at codon 344 (A344A) in FGFR2 (fibroblast
growth factor receptor II) has been observed in
four unrelated Crouzon syndrome patients.
Reardon et ar-2 thought this base substitution
would result in a new acceptor splice site. Jabs
et a!'3 suggested the mutation could create
either an acceptor or donor splice site.
Recently, Li et al,24 using RT-PCR and RNA
isolated from cell cultures of their affected sub-
ject, showed that the A344A mutation created
a new donor splice site. This finding was
confirmed independently by Del Gatto and
Brethnach25 using cloned genes in cultured
HeLa cells. Richard and Beckman26 found a
silent C-*T substitution in codon 624 of the
calpain gene (CANP3) in a homozygous
patient from one family with limb girdle mus-
cular dystrophy (LGMD2A). Analyses of
illegitimate transcripts showed an abnormal
product which, upon sequencing, was found to
be missing the last 44 bases of exon 16. Thus,
this neutral mutation results in the gain of a
new donor splice site. Lastly, a synonymous
substitution (G2142A; S649S) in exon I1 pre-
sumably created a new acceptor splice site giv-
ing rise to a truncated RET proto-oncogene
protein in members of a family with Hirsch-
sprung disease.2
Most certainly the C924T mutation in
LiCAM would have appeared as an altered
transcript using RT-PCR. Indeed, at least two
neutral mutations have been detected in this
manner, both involving the XNP gene in two
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unrelated male patients with the ATR-X
syndrome.28 29 In neither paper, however, was
the "neutral" nature of the mutation stressed
since the method of detection involved RT-
PCR. Unfortunately, in many instances, use of
genomic DNA rather than mRNA is better
suited for mutational analysis. For one thing, a
cell line is not always available for a dead
proband while DNA may have been obtained
at some time before death. Second, not all
genes are expressed in lymphocytes which are
the most readily accessible source of
mRNA.30 31 Finally, some genes are quite large,
making it difficult if not problematical to obtain
full length mRNA for analysis.
The silent mutation in Li CAM that was
identified in our family with HSAS has
enormous implications for mutation screening
in any gene. The concept of a synonymous or
neutral mutation should be altered when one is
screening a candidate gene for disease causing
mutations. A neutral base substitution can
clearly have a profound effect on mRNA splic-
ing or even codon usage, even though the
nucleotide replacement is irrelevant with re-
spect to the amino acid encoded by the codon.
Thus, it would be wise to remember the words
of Sherlock Holmes: "We must fall back upon
the old axiom that when all other contingencies
fail, whatever remains, however improbable,
must be the truth."32
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